Polynovo (PNV) Short Interest
Polynovo (ASX:PNV) had 8.70% of shares reported as short positions as of 24 Aug 2026, representing 60,112,656 shares. Polynovo operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Polynovo
PolyNovo specializes in developing and commercializing advanced medical devices using its proprietary NovoSorb technology. The company focuses on treating burns, surgical wounds, and providing solutions for Negative Pressure Wound Therapy, positioning itself as a leader in innovative healthcare solutions.
Short position
Polynovo (ASX:PNV) has 8.70% of its shares on issue reported as short positions as of 24 Aug 2026, or about 60,112,656 shares. Over the past 30 days that figure has fallen 0.29 percentage points, and over 90 days it has fallen 1.51 percentage points. Its highest recorded short interest was 14.35% in April 2026. PNV is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4PNV intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Polynovo
Latest PNV news
All newsAbout
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss PNV
Start a research thread or post the first pulse update